4/16
07:02 am
abcl
Sky bridge to connect new state-of-the-art research facility to Vancouver's St. Paul's hospital [Globe and Mail, The (Toronto, Canada)]
Low
Report
Sky bridge to connect new state-of-the-art research facility to Vancouver's St. Paul's hospital [Globe and Mail, The (Toronto, Canada)]
4/8
12:20 pm
abcl
AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024 [Yahoo! Finance]
Low
Report
AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024 [Yahoo! Finance]
4/8
12:05 pm
abcl
AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024
Low
Report
AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024
4/3
04:05 pm
abcl
AbCellera to Report First Quarter 2024 Financial Results on May 7, 2024
Low
Report
AbCellera to Report First Quarter 2024 Financial Results on May 7, 2024
3/19
04:19 pm
abcl
AbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024 [Yahoo! Finance]
Low
Report
AbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024 [Yahoo! Finance]
3/19
04:05 pm
abcl
AbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024
Low
Report
AbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024
3/11
09:12 am
abcl
AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditions [Yahoo! Finance]
Low
Report
AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditions [Yahoo! Finance]
3/11
09:00 am
abcl
AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditions
Low
Report
AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditions
3/5
04:43 pm
abcl
AbCellera Announces Four Presentations on T-Cell Engagers at AACR 2024 [Yahoo! Finance]
Low
Report
AbCellera Announces Four Presentations on T-Cell Engagers at AACR 2024 [Yahoo! Finance]
3/5
04:30 pm
abcl
AbCellera Announces Four Presentations on T-Cell Engagers at AACR 2024
Low
Report
AbCellera Announces Four Presentations on T-Cell Engagers at AACR 2024
2/29
06:45 am
abcl
After losing 38% in the past year, AbCellera Biologics Inc. (NASDAQ:ABCL) institutional owners must be relieved by the recent gain [Yahoo! Finance]
Low
Report
After losing 38% in the past year, AbCellera Biologics Inc. (NASDAQ:ABCL) institutional owners must be relieved by the recent gain [Yahoo! Finance]
2/23
04:48 pm
abcl
AbCellera Announces Resignation of Board Member [Yahoo! Finance]
Low
Report
AbCellera Announces Resignation of Board Member [Yahoo! Finance]
2/23
04:30 pm
abcl
AbCellera Announces Resignation of Board Member
Low
Report
AbCellera Announces Resignation of Board Member
2/22
08:19 pm
abcl
AbCellera to Present at Upcoming Investor Conferences in March [Yahoo! Finance]
Low
Report
AbCellera to Present at Upcoming Investor Conferences in March [Yahoo! Finance]
2/22
08:15 pm
abcl
AbCellera to Present at Upcoming Investor Conferences in March
Low
Report
AbCellera to Present at Upcoming Investor Conferences in March
2/22
07:11 am
abcl
AbCellera Biologics Inc. (NASDAQ: ABCL) was upgraded by analysts at Benchmark Co. from a "hold" rating to a "buy" rating. They now have a $9.00 price target on the stock.
Low
Report
AbCellera Biologics Inc. (NASDAQ: ABCL) was upgraded by analysts at Benchmark Co. from a "hold" rating to a "buy" rating. They now have a $9.00 price target on the stock.
2/21
09:37 am
abcl
AbCellera Biologics Inc. (NASDAQ:ABCL) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
AbCellera Biologics Inc. (NASDAQ:ABCL) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
2/21
09:22 am
abcl
AbCellera Biologics Inc. (NASDAQ: ABCL) had its price target lowered by analysts at Stifel Nicolaus from $21.00 to $17.00. They now have a "buy" rating on the stock.
Medium
Report
AbCellera Biologics Inc. (NASDAQ: ABCL) had its price target lowered by analysts at Stifel Nicolaus from $21.00 to $17.00. They now have a "buy" rating on the stock.
2/20
11:22 pm
abcl
AbCellera Biologics (ABCL) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
High
Report
AbCellera Biologics (ABCL) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
2/20
08:26 pm
abcl
AbCellera Biologics Inc. (ABCL) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates [Yahoo! Finance]
High
Report
AbCellera Biologics Inc. (ABCL) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates [Yahoo! Finance]
2/20
05:15 pm
abcl
AbCellera Biologics Inc (ABCL) Faces Net Loss in FY 2023 Amid Strategic Shifts [Yahoo! Finance]
Medium
Report
AbCellera Biologics Inc (ABCL) Faces Net Loss in FY 2023 Amid Strategic Shifts [Yahoo! Finance]
2/20
04:16 pm
abcl
AbCellera Reports Full Year 2023 Business Results [Yahoo! Finance]
Medium
Report
AbCellera Reports Full Year 2023 Business Results [Yahoo! Finance]
2/20
04:05 pm
abcl
AbCellera Reports Full Year 2023 Business Results
Medium
Report
AbCellera Reports Full Year 2023 Business Results
2/13
04:19 pm
abcl
AbCellera Biologics: Continuing To Expand Partnerships [Seeking Alpha]
Low
Report
AbCellera Biologics: Continuing To Expand Partnerships [Seeking Alpha]
2/1
09:10 am
abcl
Techne (TECH) Q2 Earnings and Revenues Lag Estimates [Yahoo! Finance]
Low
Report
Techne (TECH) Q2 Earnings and Revenues Lag Estimates [Yahoo! Finance]